1. Cell Biology

Erk regulation of actin capping and bundling by Eps8 promotes cortex tension and leader bleb-based migration

  1. Jeremy S Logue
  2. Alexander X Cartagena-Rivera
  3. Michelle A Baird
  4. Michael W Davidson
  5. Richard S Chadwick
  6. Clare M Waterman  Is a corresponding author
  1. National Institutes of Health, United States
  2. Florida State University, United States
https://doi.org/10.7554/eLife.08314
Share this article
Cite this article
  1. Jeremy S Logue
  2. Alexander X Cartagena-Rivera
  3. Michelle A Baird
  4. Michael W Davidson
  5. Richard S Chadwick
  6. Clare M Waterman
(2015)
Erk regulation of actin capping and bundling by Eps8 promotes cortex tension and leader bleb-based migration
eLife 4:e08314.
https://doi.org/10.7554/eLife.08314
  2. Download BibTeX
  3. Download .RIS

Abstract

Within the confines of tissues, cancer cells can use blebs to migrate. Eps8 is an actin bundling and capping protein whose capping activity is inhibited by Erk, a key MAP kinase that is activated by oncogenic signaling. We tested the hypothesis that Eps8 acts as an Erk effector to modulate actin cortex mechanics and thereby mediate bleb-based migration of cancer cells. Cells confined in a non-adhesive environment migrate in the direction of a very large 'leader bleb.' Eps8 bundling activity promotes cortex tension and intracellular pressure to drive leader bleb formation. Eps8 capping and bundling activities act antagonistically to organize actin within leader blebs, and Erk mediates this effect. An Erk biosensor reveals concentrated kinase activity within leader blebs. Bleb contents are trapped by the narrow neck that separates the leader bleb from the cell body. Thus, Erk activity promotes actin bundling by Eps8 to enhance cortex tension and drive the bleb-based migration of cancer cells under non-adhesive confinement.

Article and author information

Author details

  1. Jeremy S Logue

    National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.

  2. Alexander X Cartagena-Rivera

    National Institute on Deafness and other Communication Disorders, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.

  3. Michelle A Baird

    National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.

  4. Michael W Davidson

    National High Magnetic Field Laboratory and Department of Biological Science, Florida State University, Tallahassee, United States
    Competing interests
    No competing interests declared.

  5. Richard S Chadwick

    National Institute on Deafness and other Communication Disorders, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.

  6. Clare M Waterman

    National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, United States
    For correspondence
    watermancm@nhlbi.nih.gov
    Competing interests
    Clare M Waterman, Reviewing editor for eLife.

Reviewing Editor

  1. Pekka Lappalainen, University of Helsinki, Finland

Version history

  1. Received: April 24, 2015
  2. Accepted: July 10, 2015
  3. Accepted Manuscript published: July 11, 2015 (version 1)
  4. Accepted Manuscript updated: July 14, 2015 (version 2)
  5. Version of Record published: August 3, 2015 (version 3)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 4,501
    views
  • 788
    downloads
  • 97
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jeremy S Logue
  2. Alexander X Cartagena-Rivera
  3. Michelle A Baird
  4. Michael W Davidson
  5. Richard S Chadwick
  6. Clare M Waterman
(2015)
Erk regulation of actin capping and bundling by Eps8 promotes cortex tension and leader bleb-based migration
eLife 4:e08314.
https://doi.org/10.7554/eLife.08314

Share this article

https://doi.org/10.7554/eLife.08314

Categories and tags

Research organism

Further reading

    1. Cell Biology

    Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease

    Yuki Date, Yukiko Sasazawa ... Shinji Saiki
    Research Article Updated

    The autophagy-lysosome pathway plays an indispensable role in the protein quality control by degrading abnormal organelles and proteins including α-synuclein (αSyn) associated with the pathogenesis of Parkinson’s disease (PD). However, the activation of this pathway is mainly by targeting lysosomal enzymic activity. Here, we focused on the autophagosome-lysosome fusion process around the microtubule-organizing center (MTOC) regulated by lysosomal positioning. Through high-throughput chemical screening, we identified 6 out of 1200 clinically approved drugs enabling the lysosomes to accumulate around the MTOC with autophagy flux enhancement. We further demonstrated that these compounds induce the lysosomal clustering through a JIP4-TRPML1-dependent mechanism. Among them, the lysosomal-clustering compound albendazole promoted the autophagy-dependent degradation of Triton-X-insoluble, proteasome inhibitor-induced aggregates. In a cellular PD model, albendazole boosted insoluble αSyn degradation. Our results revealed that lysosomal clustering can facilitate the breakdown of protein aggregates, suggesting that lysosome-clustering compounds may offer a promising therapeutic strategy against neurodegenerative diseases characterized by the presence of aggregate-prone proteins.

    1. Cancer Biology
    2. Cell Biology

    CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake

    Savvas Nikolaou, Amelie Juin ... Laura M Machesky
    Research Article Updated

    Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring enhanced migratory and proliferative capacity as well as macropinocytosis. Macropinocytosis is well understood as a nutrient scavenging mechanism, but little is known about its functions in trafficking of signalling receptors. We find that CYRI-B is highly expressed in pancreatic tumours in a mouse model of KRAS and p53-driven pancreatic cancer. Deletion of Cyrib (the gene encoding CYRI-B protein) accelerates tumourigenesis, leading to enhanced ERK and JNK-induced proliferation in precancerous lesions, indicating a potential role as a buffer of RAC1 hyperactivation in early stages. However, as disease progresses, loss of CYRI-B inhibits metastasis. CYRI-B depleted tumour cells show reduced chemotactic responses to lysophosphatidic acid, a major driver of tumour spread, due to impaired macropinocytic uptake of the lysophosphatidic acid receptor 1. Overall, we implicate CYRI-B as a mediator of growth and signalling in pancreatic cancer, providing new insights into pathways controlling metastasis.

    1. Cell Biology
    2. Physics of Living Systems

    Cell Migration: Pump up the volume

    Qin Ni, Sean X Sun
    Insight

    An influx of water molecules can help immune cells called neutrophils to move to where they are needed in the body.